|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 7 of 17 found articles
| Title: |
JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study |
| Author: |
Uemura, Yu Yamamoto, Masahide Ishimura, Masataka Kanegane, Hirokazu Sawada, Akihisa Hirakawa, Akihiro Imadome, Ken-Ichi Yoshimori, Mayumi Nagata, Masashi Yamamoto, Kouhei Shimizu, Norio Koike, Ryuji Arai, Ayako |
| Appeared in: |
Blood neoplasia |
| Paging: | Volume 2 () nr. 1 pages p. |
| Year: |
2025 |
| Contents: | |
| Publisher: |
The American Society of Hematology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 7 of 17 found articles
| << previous | next >> |